Table 2.
Patients with histological recurrence of IgAN, significant young recipient’s age.
| Total cohort | Histological recurrence of IgAN | |||
|---|---|---|---|---|
| n = 313 | yes (n = 44) | no (n = 269) | p value | |
| Recipient age, years [range] | 46 [20,79] | 38 [20,62] | 47 [22,79] | <0.0001 |
| Recipient gender, male, n (%) | 253 (81%) | 35 (80%) | 218 (81%) | 0.837 |
| Donor age, years [range] | 53 [6,81] | 53 [21,73] | 53 [6,81] | 0.588 |
| Donor gender, male, n (%) | 135 (43%) | 14 (49%) | 121 (36%) | 0.167 |
| Retransplantation, n (%) | 33 (10.5%) | 9 (21%) | 24 (9%) | 0.032 |
| Living donor, n (%) | 90 (29%) | 14 (32%) | 76 (28%) | 0.72 |
| Peak PRA [range] | 4 [0,96] | 4 [0,96] | 4 [0,92] | 0.757 |
| HLA mismatch [range] | 3 [0,6] | 3 [2,6] | 3 [0,6] | 0.856 |
| Dialysis vintage, months [range] | 16 [0,97] | 16 [0,78] | 16 [0,97] | 0.694 |
| Cold ischemia, hours [range] | 13 [0,26] | 13 [0,23] | 13 [0,26] | 0.882 |
| Erythrocyturia post Tx | 74 (24%) | 29 (65.9%) | 45 (17.3%) | <0.001 |
| Proteinuria post Tx | 90 (29%) | 33 (75%) | 57 (21.2%) | <0.001 |
| Follow-up, years [range] | 5 [0, 21] | 6 [0.5, 15] | 4 [0, 21] | 0.881 |
| Graft failure n (%) | 58 (18.5%) | 23 (52.3%) | 35 (13%) | <0.001 |
| Time to graft failure, years [range] | 5 [6.3,17.5] | 6.9 [2.5,15.4] | 5.3 [0.03,17.5] | 0.074 |